Treatment of transplant-eligible patients with multiple myeloma in 2014 Journal Article

  


Authors: Landau, H.; Giralt, S.
Article Title: Treatment of transplant-eligible patients with multiple myeloma in 2014
Abstract: Induction regimens containing a proteasome inhibitor and/or immunomodulatory agent with dexamethasone result in rapid disease control before autologous stem cell transplantation (ASCT). ASCT followed by consolidation and/or maintenance further improves depth of response following effective induction. Overall survival of transplant-eligible patients has been extended with modern therapeutic strategies. The optimal timing of ASCT and methods to prevent relapse following ASCT are under active investigation. Different patient populations may benefit differentially from currently available treatments.
Keywords: dexamethasone; melphalan; stem cell transplantation; toxicity; corticosteroids
Journal Title: Hematology/Oncology Clinics of North America
Volume: 28
Issue: 5
ISSN: 0889-8588
Publisher: Elsevier Inc.  
Date Published: 2014-10-01
Start Page: 815
End Page: 827
Language: English
DOI: 10.1016/j.hoc.2014.06.004
PROVIDER: scopus
PUBMED: 25212884
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-84912574090&partnerID=40&md5=a511896030118144e2839d1fbf12d8ab
Notes: Export Date: 2 January 2015 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1051 Giralt
  2. Heather Jolie Landau
    419 Landau
Related MSK Work